Who are Fortis Therapeutics's investors?

Fortis Therapeutics's investors include Vivo Capital, Lilly Asia Ventures, Osage University Partners, Avalon BioVentures, OUP (Osage University Partners).

How much funding has Fortis Therapeutics raised?

Fortis Therapeutics has disclosed $40M raised across 1 of its 4 known rounds.

Where is Fortis Therapeutics headquartered?

Fortis Therapeutics is headquartered in San Diego, US.

Fortis Therapeutics

San Diego, US · 7 known investors

Find your way into Fortis Therapeutics

Your email: who you already know at Fortis Therapeutics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fortis Therapeutics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas. The company is backed by multiple life sciences investment firms and operates from San Diego.

Biotech Healthtech Medical Devices

Founders & leadership

Marc NasoffChief Scientific Officer

F. Andrew DorrMedical Oncologist

Board

Jay B. Lichter Ph.D.Managing Partner at Avalon BioVentures

Investors · 7

Vivo Capital✓ confirmed by Fortis TherapeuticsPalo Alto · $10M – $50M

How we know: Vivo Capital's portfolio page · the company's own site · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Lilly Asia Ventures✓ confirmed by Fortis TherapeuticsHong Kong

How we know: the company's own site · funding news · prnewswire.com · Not right? Tell us

Osage University Partners✓ confirmed by Fortis TherapeuticsBala Cynwyd

How we know: the company's own site · funding news · prnewswire.com · Not right? Tell us

Avalon BioVentureslisted by Avalon BioVenturesLa Jolla

How we know: Avalon BioVentures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us

Also in the syndicate · 2

Bregua Corp.Bregua Corporation

Funding

SEC filings, press & company announcements

$40M disclosed across 1 of 4 rounds · 2016–2021

$40MSeries AMar 2021 · 2 sources
Source ↗
Undisclosed amountSeries ANov 2018
Source ↗
Undisclosed amountSeries ASep 2016
Avalon Ventures (lead), Bregua Corporation, Lilly Asia Ventures, Osage University Partners, Vivo Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Fortis Therapeutics Closes $40 Million Series A Financing to Advance Novel Anti-CD46 Therapeutic to Treat Late-Stage Prostate Cancer and Multiple Myeloma - Fortis Therapeuticsfortistx.com · Mar 2021

News - Fortis Therapeuticsfortistx.com · Mar 2021

Fortis Therapeutics Closes $18 Million Series A Financingfortistx.com · Nov 2018

Frequently asked questions

What does Fortis Therapeutics do?: Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas. The company is backed by multiple life sciences investment firms and operates from San Diego.
Who are Fortis Therapeutics's investors?: Fortis Therapeutics's investors include Vivo Capital, Lilly Asia Ventures, Osage University Partners, Avalon BioVentures, OUP (Osage University Partners).
How much funding has Fortis Therapeutics raised?: Fortis Therapeutics has disclosed $40M raised across 1 of its 4 known rounds.
Where is Fortis Therapeutics headquartered?: Fortis Therapeutics is headquartered in San Diego, US.